Widespread US shift from prescription to OTC lies in pharma’s hands
In an interview from February 2026, commissioner of the US Food and Drug Administration (FDA), Marty Makary, said that “everything…
Analysis
Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience
Building for decades: Dubai’s long game in life sciences
Eli Lilly Injectable Medicine and Device Manufacturing Facility, Pennsylvania, US
Women first: the Gulf’s new healthcare blueprint
Targeted therapies to join chemo as oncology treatment backbone
Europe’s pharma trade with the US remains critical despite tariff turmoil
How America’s former steel heartland secured a $3.5bn Eli Lilly facility
